-
Simcere Pharmaceutical's application for anti-new crown innovative drug was accepted, and it is a Pf...
The latest developments!
2023-01-18 16:50 -
Officially cut into the CAR-T track! Huadong Medicine obtained the commercialization rights of Zewok...
200 million yuan down payment, and up to 1.025 billion yuan of registration and sales milestone payment.
2023-01-18 16:48 -
Taking P drug and oseltamivir as an example, let's talk about the logic of national talk and nationa...
A brief analysis of the economic logic of national talk and national procurement.
2023-01-18 16:45 -
Bio-Thera's world's first tocilizumab biosimilar was approved for marketing in China
The indications are rheumatoid arthritis, systemic juvenile idiopathic arthritis and cytokine release syndrome.
2023-01-18 16:42 -
Colonbotai SKB264 (MK-2870) combined with osimertinib was approved for clinical trials
Encouraging antitumor activity was shown in patients who failed EGFR-TKI therapy.
2023-01-18 16:41 -
NEJM: Seriously consider VV116+Paxlovid combination
VV116 vs. Paxlovid head-to-head comparison
2023-01-18 16:41 -
Annual inventory: Under the cold winter, these companies will fall in 2022
How hard is 2022?
2023-01-18 16:39 -
When will the new crown medicine rush stop shopping? Coenzyme Q10 is 'popular' again...
Can coenzyme Q10 really prevent myocarditis caused by the new crown?
2023-01-16 15:58 -
First-line SQ-NSCLC approved! Akeso benefits a large population of lung cancer patients
It is used in combination with chemotherapy for the first-line treatment of locally advanced or metastatic squamous non-small cell lung cancer.
2023-01-16 15:56 -
The State Food and Drug Administration accepted the marketing application of Ditze Pharma suvortinib
National innovative drugs break through the refractory target of lung cancer
2023-01-11 16:45
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products
Related Producers
